2013 AIChE Annual Meeting

Session: Holistic Product Development: A Journey From Drug Discovery to Clinical Reality

This sessions seeks contributions that link the multiple steps of development and promote the cross-discipline interactions. Holistic product developmet will enable an upstream design guiding development desicions to fullfill clinical needs.

Chair

Schild, R., Bristol-Myers Squibb

Co-Chairs

Burcham, C. L., Eli Lilly and Company
Am Ende, M. T., Pfizer Global Research and Development
Collins, P., Eli Lilly

Presentations

03:15 PM

(178a) A Novel Computational Oral Absorption Simulation Tool to Integrate API Crystal Properties and Drug Product Design Attributes to in Vitro and in Vivo Performance
Sagawa, K., Shanker, R. M., Li, R., Bermingham, S. K., Braido, D., Calado, F., Abbou Oucherif, K.

03:35 PM

(178b) Differential Diagnosis of Primary Hyperparathyroidism and Extent of Progression Through Short-Term Calcium Loading
Christie, C. R., Achenie, L. E. K., Ogunnaike, B. A.

03:55 PM

(178c) Polymer Inhibition of Crystal Growth for Improved Drug Solubility
Schram, C., Beaudoin, S., Taylor, L.

04:15 PM

(178d) Experiences in the Corporate-Wide Deployment of Advanced Modeling Technology: Making the Complicated Look Simple, But No Simpler Than That!
Garcia-Munoz, S., Schmitz, P.

04:45 PM

(178e) Crystallization of Active Pharmaceutical Ingredient in Drug Product: A Case Study
Dai, W.

05:05 PM

(178f) Quality By Design in Integrated Processes: From Drug Substance to Drug Product
Gil, M. Sr., Gaspar, F., Matos, N.

05:25 PM

(178g) Concomitant Co-Crystallization On Engineered Surfaces
Shi, X., Wong, S. Y., Myerson, A. S., Yang, X.